From concept to commercialization, key life science insights are critical through every aspect of the drug and device development life cycle. In a recent insights management webinar, we discussed how gaining these insights has always been difficult and time-consuming – in an increasingly global business, it’s becoming even more complex.
To save time and build on existing relationships, medical affairs professionals typically engage the same KOLs repeatedly. While this may provide a level of familiarity, teams may be unintentionally limiting the insights they gather. And once input is collected, the notes and raw transcripts can take weeks to translate into actionable insights. Collaboration across the enterprise is often hindered by siloed data sets stored in different systems across multiple teams.
Recently, Within3 CEO Lance Hill and Mike Abbadessa, Within3 Executive Director of Clinical Affairs were joined by Raymond Mankoski of The NemetzGroup to discuss closing the life science insight gap to inform more efficient business decisions.
Highlights of the conversation included:
- Live feedback from the audience on the biggest problems they face when tackling the insights gap – top responses included a lack of time and the difficulty of getting full participation from expert stakeholders
- A preview of Within3’s insights management platform, which organizes insight-gathering in a single solution
Watch the insights management webinar.